BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

XLVIvsFHLCETF Comparison

ETF 1

XLVI

State Street Health Care Select Sector SPDR Premium Income Fund

This fund is part of

Options Strategies

-0.72%

Full XLVI fund page

VS

ETF 2

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

+0.4%

Full FHLC fund page

State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. Fidelity MSCI Health Care Index ETF (FHLC) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: Healthcare and Consumer Non-Cyclicals. XLVI is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.084% for FHLC. XLVI is up 5.2% year-to-date (YTD) with +$7M in YTD flows. FHLC performs worse with 5.05% YTD performance, and +$244M in YTD flows. Run a side-by-side ETF comparison of XLVI and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

XLVI vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 07/22/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	XLVI FHLC	+3.88%+6.35%	+7.81%+9.86%	+5.20%+5.05%	n/a+23.88%	n/a+25.61%	n/a+27.55%
Flows	XLVI FHLC	+$2M+$20M	+$5M+$112M	+$7M+$244M	-+$275M	--$452M	--$77M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	XLVI FHLC	+12.38%+17.56%	n/a+15.35%	n/a+14.36%	n/a+15.25%
Max drawdown	XLVI FHLC	-2.06%-3.84%	n/a-10.35%	n/a-16.88%	n/a-17.78%
Max drawdown duration	XLVI FHLC	7d15d	n/a169d	n/a435d	n/a762d

Trading data

Create an account to view trading data

Join for free

	XLVI	FHLC
Last sale 7/24/2026 at 5:56 PM	$26.51	$78.80
Previous close 07/23/2026	$26.33	$78.40
Consolidated volume 07/23/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of June 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

XLVI

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	XLVI	FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 7/24/2026 at 5:56 PM

Live

Closed

	XLVI	FHLC
Last price	$26.51	$78.80
1D performance	+0.67%	+0.51%
AuM	$18.27 M	$3.22 B
E/R	0.35%	0.084%

Characteristics

	XLVI	FHLC
Management strategy	Active	Passive
Provider	State Street Investment Management	Fidelity
Benchmark	-	MSCI USA IMI Health Care 25/50 Index
N° of holdings	59	333
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	July 30, 2025	October 21, 2013
ESG	No	No

More XLVI data on Trackinsight

More FHLC data on Trackinsight

Exposure

Countries

XLVI

USA

100.53%

Other

-0.53%

FHLC

USA

96.98%

Other

3.02%

Sectors

XLVI

Healthcare

100.33%

Other

-0.33%

FHLC

Healthcare

97.66%

Other

2.34%

Diversification

XLVI

Total weight of top 15 holdings out of 15

74.76%

FHLC

Total weight of top 15 holdings out of 15

61.21%

Top 15 holdings

Data as of June 30, 2026

XLVI

Eli Lilly & Co.

17.01%

Johnson & Johnson

10.96%

AbbVie, Inc.

7.97%

UnitedHealth Group, Inc.

6.77%

Merck & Co., Inc.

5.69%

Amgen, Inc.

3.50%

Thermo Fisher Scientific, Inc.

3.34%

Abbott Laboratories

2.83%

Gilead Sciences, Inc.

2.81%

Intuitive Surgical, Inc.

2.53%

Pfizer Inc.

2.46%

CVS Health Corp.

2.37%

Vertex Pharmaceuticals, Inc.

2.26%

Danaher Corp.

2.15%

Bristol Myers Squibb Co.

2.11%

FHLC

Eli Lilly & Co.

13.60%

Johnson & Johnson

8.86%

AbbVie, Inc.

6.46%

UnitedHealth Group, Inc.

5.67%

Merck & Co., Inc.

4.66%

Amgen, Inc.

2.86%

Thermo Fisher Scientific, Inc.

2.82%

Abbott Laboratories

2.44%

Gilead Sciences, Inc.

2.31%

Intuitive Surgical, Inc.

2.13%

Pfizer Inc.

2.02%

CVS Health Corp.

2.00%

Danaher Corp.

1.84%

Vertex Pharmaceuticals, Inc.

1.83%

Bristol Myers Squibb Co.

1.70%

Frequently asked questions about XLVI and FHLC

How have the XLVI and FHLC ETFs performed in 2026?

As of July 22, 2026, XLVI is up 5.2% year-to-date (YTD), while FHLC has returned 5.05%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: XLVI or FHLC?

Year-to-date, the XLVI ETF saw +$7M in flows, compared to +$244M for FHLC.

Which ETF is bigger: XLVI or FHLC?

As of July 22, 2026, XLVI holds $18.27 M in assets under management (AUM), while FHLC manages $3.22 B.

What sectors do the XLVI and FHLC ETFs invest in?

XLVI leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the XLVI ETF and FHLC ETF?

XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

XLVIvsFHLCETF Comparison

State Street Health Care Select Sector SPDR Premium Income Fund

Fidelity MSCI Health Care Index ETF

XLVI vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the XLVI and FHLC ETFs performed in 2026?

As of July 22, 2026, XLVI is up 5.2% year-to-date (YTD), while FHLC has returned 5.05%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: XLVI or FHLC?

Year-to-date, the XLVI ETF saw +$7M in flows, compared to +$244M for FHLC.

Which ETF is bigger: XLVI or FHLC?

As of July 22, 2026, XLVI holds $18.27 M in assets under management (AUM), while FHLC manages $3.22 B.

What sectors do the XLVI and FHLC ETFs invest in?

XLVI leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the XLVI ETF and FHLC ETF?

XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: XLVI or FHLC?

XLVI holds 59 securities with 74.76% of its assets in the top 15. FHLC has 337 securities and a top 15 weight of 61.21%.

The ETF Industry Is Evolving Fast